Reviewed profile

food and beverage brand · public preview

Marinus

Retail brand

Public category
Retail brand
Products tracked
1
Brand tier
private-label brand
Headquarters
United States
Is this your company?Claim Marinus to get found by buyers, add products and certifications, correct your details, and be eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to Marinus — no cold outreach.
Report a changeLog in for full recordLast reviewed 19 Jun 2026 · public preview data

Overview

What Marinus covers.

Marinus Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for patients with rare genetic epilepsies and other seizure disorders. The company's primary product, Ztalmy, is a neuroactive steroid indicated for the treatment of seizures associated with CDKL5 deficiency disorder. Marinus operates as a clinical-stage and commercial-stage organization dedicated to addressing unmet medical needs in neurology.

  • Talio tracks 1 product for Marinus.
  • Positioned as a private-label brand.
  • Headquartered in United States.

FAQ

Questions this page answers.

What does Marinus do?

Marinus is a food and beverage brand based in United States, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Claim this pageLog in for full recordReport a change

Public preview data only · proprietary metrics remain in authenticated Talio.